<- Go Home

Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Market Cap

SEK 15.6B

Volume

238.6K

Cash and Equivalents

SEK 455.3M

EBITDA

SEK 322.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 1.1B

Profit Margin

92.48%

52 Week High

SEK 346.40

52 Week Low

SEK 165.00

Dividend

N/A

Price / Book Value

16.58

Price / Earnings

85.33

Price / Tangible Book Value

16.85

Enterprise Value

SEK 15.1B

Enterprise Value / EBITDA

45.81

Operating Income

SEK 320.1M

Return on Equity

22.04%

Return on Assets

19.86

Cash and Short Term Investments

SEK 455.3M

Debt

SEK 14.1M

Equity

SEK 938.9M

Revenue

SEK 1.2B

Unlevered FCF

SEK 204.7M

Sector

Biotechnology

Category

N/A

Company Stock Pitches